Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling

Molecular and Cellular Biology

Volumn 27, Issue 12, 2007, Pages 4566-4577

  Nakamura, Kazuhiro ^a   Johnson, Gary L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; EMBRYO; FIBROBLASTS; MAP KINASE KINASE 5; MAP KINASE KINASE 7; MAP KINASE KINASE KINASE 2; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 7; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 34250215694     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00125-07     Document Type: Article

References (37)

1. Bardwell, A. J., L. J. Flatauer, K. Matsukuma, J. Thorner, and L. Bardwell. 2001. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. J. Biol. Chem. 276:10374-10386.
2. Bardwell, L. 2006. Mechanisms of MAPK signalling specificity. Biochem. Soc. Trans. 34:837-841.
3. Bogoyevitch, M. A. 2005. Therapeutic promise of JNK ATP-noncompetitive inhibitors. Trends Mol. Med. 11:232-239.
4. Chang, C. I., B. E. Xu, R. Akella, M. H. Cobb, and E. J. Goldsmith. 2002. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9:1241-1249.
5. Chayama, K., P. J. Papst, T. P. Garrington, J. C. Pratt, T. Ishizuka, S. Webb, S. Ganiatsas, L. I. Zon, W. Sun, G. L. Johnson, and E. W. Gelfand. 2001. Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells. Proc. Natl. Acad. Sci. USA 98:4599-4604.
6. Cheng, J., J. Yang, Y. Xia, M. Karin, and B. Su. 2000. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Mol. Cell. Biol. 20:2334-2342.
7. Cheng, J., L. Yu, D. Zhang, Q. Huang, D. Spencer, and B. Su. 2005. Dimerization through the catalytic domain is essential for MEKK2 activation. J. Biol. Chem. 280:13477-13482.
8. Garrington, T. P., T. Ishizuka, P. J. Papst, K. Chayama, S. Webb, T. Yujiri, W. Sun, S. Sather, D. M. Russell, S. B. Gibson, G. Keller, E. W. Gelfand, and G. L. Johnson. 2000. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J. 19:5387-5395.
9. Hayashi, M., and J. D. Lee. 2004. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 82:800-808.
10. Hirano, Y., S. Yoshinaga, K. Ogura, M. Yokochi, Y. Noda, H. Sumimoto, and F. Inagaki. 2004. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5. J. Biol. Chem. 279: 31883-31890.
11. Hirano, Y., S. Yoshinaga, R. Takeya, N. N. Suzuki, M. Horiuchi, M. Kohjima, H. Sumimoto, and F. Inagaki. 2005. Structure of a cell polarity regulator, a complex between atypical PKC and Part PB1 domains. J. Biol. Chem. 280: 9653-9661.
12. Holland, P. M., and J. A. Cooper. 1999. Protein modification: docking sites for kinases. Curr. Biol. 9:R329-R331.
13. Lamark, T., M. Perander, H. Outzen, K. Kristiansen. A. Overvatn, E. Michaelsen, G. Bjorkoy, and T. Johansen. 2003. Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J. Biol. Chem. 278:34568-34581.
14. Lin, Q., J. Schwarz, C. Bucana, and E. N. Olson. 1997. Control of mouse-cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
15. Morrison, D. K. 2001. KSR: a MAPK scaffold of the Ras pathway? J. Cell Sci. 114:1609-1612.
16. Moscat, J., M. T. Diaz-Meco, A. Albert, and S. Campuzano. 2006. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23:631-640.
17. Nakamura, K., and G. L. Johnson. 2003. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERICS pathway. J. Biol. Chem. 278:36989-36992.
18. Nakamura, K., M. T. Uhlik, N. L. Johnson, K. M. Hahn, and G. L. Johnson. 2006. PB1 domain-dependent signaling complex is required for ERK5 activation. Mol. Cell. Biol. 26:2065-2079.
19. Noda, Y., M. Kohjima, T. Izaki, K. Ota, S. Yoshinaga, F. Inagaki, T. Ito, and H. Sumimoto. 2003. Molecular recognition in dimerization between PB1 domains. J. Biol. Chem. 278:43516-43524.
20. Pearson, G. W., S. Earnest, and M. H. Cobb. 2006. Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. Mol. Cell. Biol. 26:3039-3047.
21. Ranganathan, A., G. W. Pearson, C. A. Chrestensen, T. W. Sturgill, and M. H. Cobb. 2006. The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch. Biochem. Biophys. 449:8-16.
22. Rodriguez, A., A. Duran, M. Selloum, M. F. Champy, F. J. Diez-Guerra, J. M. Flores, M. Serrano, J. Auwerx, M. T. Diaz-Meco, and J. Moscat. 2006. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 3:211-222.
23. Rubinfeld, H., T. Hanoch, and R. Seger. 1999. Identification of a cytoplasmic-retention sequence in ERK2. J. Biol. Chem. 274:30349-30352.
24. Schwartz, M. A., and H. D. Madhani. 2004. Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. Annu. Rev. Genet. 38:725-748.
25. Seyfried, J., X. Wang, G. Kharebava, and C. Tournier. 2005. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5α organizes the components of the extracellular signal-regulated kinase 5 signaling pathway. Mol. Cell. Biol. 25:9820-9828.
26. Sharrocks, A. D., S. H. Yang, and A. Galanis. 2000. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25:448-453.
27. Takekawa, M., K. Tatebayashi, and H. Saito. 2005. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol. Cell 18:295-306.
28. Tanoue, T., M. Adachi, T. Moriguchi, and E. Nishida. 2000. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2:110-116.
29. Tanoue, T., R. Maeda, M. Adachi, and E. Nishida. 2001. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 20:466-479.
30. Tatebayashi, K., M. Takekawa, and H. Saito. 2003. A docking site determining specificity of Pbs2 MAPKK for Ssk2/Ssk22 MAPKKKs in the yeast HOG pathway. EMBO J. 22:3624-3634.
31. Tournier, C., A. J. Whitmarsh, J. Cavanagh, T. Barrett, and R. J. Davis. 1999. The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol. Cell. Biol. 19:1569-1581.
32. Uhlik, M. T., A. N. Abell, N. L. Johnson, W. Sun, B. D. Cuevas, K. E. Lobel-Rice, E. A. Horne, M. L. Dell'Acqua, and G. L. Johnson. 2003. RacMEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5:1104-1110.
33. Wang, X., A. J. Merritt, J. Seyfried, C. Guo, E. S. Papadakis, K. G. Finegan, M. Kayahara, J. Dixon, R. P. Boot-Handford, E. J. Cartwright, U. Mayer, and C. Tournier. 2005. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol. Cell Biol. 25:336-345.
34. Whitmarsh, A. J. 2006. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 34:828-832.
35. Wilson, M. I., D. J. Gill, O. Perisic, M. T. Quinn, and R. L. Williams. 2003. PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol. Cell 12:39-50.
36. Yang, J., M. Boerm, M. McCarty, C. Bucana, I. J. Fidler, Y. Zhuang, and B. Su. 2000. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24:309-313.
37. Zhang, D., V. Facchinetti, X. Wang, Q. Huang, J. Qin, and B. Su. 2006. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J. 25:97-107.